Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TOPAZIUM Smart Medicine is a private Spanish healthtech and biotech company that develops artificial-intelligence tools for drug discovery, clinical research, diagnostics, and wellness applications. The company operates a multi-domain AI platform designed to analyze chemical, genetic, preclinical, clinical, imaging, and lifestyle data to identify disease patterns, biomarkers, patient subgroups, and therapeutic opportunities. Its named products and frameworks include GFPrint for extracting clinical insight from genomic data, PredLung for oncology-related modeling, HealthGuard for personalized nutrition and health promotion, LivGuard for cirrhosis detection from liver ultrasound, and SkinGuard for skin-lesion assessment. TOPAZIUM also provides services to pharmaceutical companies, biotech firms, hospitals, academic institutions, insurers, nutraceutical companies, and medical-device manufacturers. Based on available public information, it appears to be primarily a platform and analytics company rather than a developer of proprietary therapeutic drug assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TOPAZIUM Smart Medicine.